Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: GENOMIC HEALTH, INC.
Awarding agency: Department of Defense / Department of the Air Force
Funding agency: Department of Defense / Department of the Air Force
Period of performance: 2023-03-16 to 2024-03-15
Current total value of award: $124588.79
Description: ONCOTYPE DX CANCER TESTING (ORDERING PERIOD 3)